These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1531763)

  • 41. Analysis of T cell stimulation by superantigen plus major histocompatibility complex class II molecules or by CD3 monoclonal antibody: costimulation by purified adhesion ligands VCAM-1, ICAM-1, but not ELAM-1.
    van Seventer GA; Newman W; Shimizu Y; Nutman TB; Tanaka Y; Horgan KJ; Gopal TV; Ennis E; O'Sullivan D; Grey H
    J Exp Med; 1991 Oct; 174(4):901-13. PubMed ID: 1717633
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Defective thymic T cell activation by concanavalin A and anti-CD3 in autoimmune nonobese diabetic mice. Evidence for thymic T cell anergy that correlates with the onset of insulitis.
    Zipris D; Lazarus AH; Crow AR; Hadzija M; Delovitch TL
    J Immunol; 1991 Jun; 146(11):3763-71. PubMed ID: 1827815
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The acquisition of CD4 and CD8 during the differentiation of early thymocytes in short-term culture.
    Wilson A; Petrie HT; Scollay R; Shortman K
    Int Immunol; 1989; 1(6):605-12. PubMed ID: 2518729
    [TBL] [Abstract][Full Text] [Related]  

  • 44. IL-10, a novel growth cofactor for mature and immature T cells.
    MacNeil IA; Suda T; Moore KW; Mosmann TR; Zlotnik A
    J Immunol; 1990 Dec; 145(12):4167-73. PubMed ID: 2124236
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The kinetics of T cell antigen receptor expression by subgroups of CD4+8+ thymocytes: delineation of CD4+8+3(2+) thymocytes as post-selection intermediates leading to mature T cells.
    Shortman K; Vremec D; Egerton M
    J Exp Med; 1991 Feb; 173(2):323-32. PubMed ID: 1824855
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CD28 is an inducible T cell surface antigen that transduces a proliferative signal in CD3+ mature thymocytes.
    Turka LA; Ledbetter JA; Lee K; June CH; Thompson CB
    J Immunol; 1990 Mar; 144(5):1646-53. PubMed ID: 2155264
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Murine lymphocytes exhibit heterogeneity in their proliferative responsiveness to calcium ionophore.
    Kakkanaiah VN; Nagarkatti PS; Nagarkatti M
    Cell Mol Biol (Noisy-le-grand); 1992; 38(5-6):533-43. PubMed ID: 1483106
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Factor requirements for activation and proliferation steps of human CD2+CD3-CD4-CD8- early thymocytes.
    Dalloul AH; Mossalayi MD; Dellagi K; Bertho JM; Debré P
    Eur J Immunol; 1989 Nov; 19(11):1985-90. PubMed ID: 2574677
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interleukin-4 induces expression of the CD45RA antigen on human thymocyte subpopulations.
    Uittenbogaart CH; Higashitani S; Schmid I; Vollger LW; Boone T; Clement LT
    Int Immunol; 1990; 2(12):1179-87. PubMed ID: 2151026
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A novel model for antigen-dependent activation of normal human T cells. Transmembrane signaling by crosslinkage of the CD3/T cell receptor-alpha/beta complex with the cluster determinant 2 antigen.
    Suthanthiran M
    J Exp Med; 1990 Jun; 171(6):1965-79. PubMed ID: 1972176
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of transforming growth factor-beta on human lymphokine-activated killer cell precursors. Autocrine inhibition of cellular proliferation and differentiation to immune killer cells.
    Kasid A; Bell GI; Director EP
    J Immunol; 1988 Jul; 141(2):690-8. PubMed ID: 3133414
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Heterodimeric complex formation with CD8 and TCR by bispecific antibody sustains paracrine IL-2-dependent growth of CD3+ CD8+ T cells.
    De Lau WB; Boom SE; Heije K; Griffioen AW; Braakman E; Bolhuis RL; Tax WJ; Clevers H; Bast BJ
    J Immunol; 1992 Sep; 149(6):1840-6. PubMed ID: 1387662
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clonal analysis of functionally distinct human CD4+ T cell subsets.
    Rotteveel FT; Kokkelink I; van Lier RA; Kuenen B; Meager A; Miedema F; Lucas CJ
    J Exp Med; 1988 Nov; 168(5):1659-73. PubMed ID: 2903211
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Generation propagation, and targeting of human CD4+ helper/killer T cells induced by anti-CD3 monoclonal antibody plus recombinant IL-2. An efficient strategy for adoptive tumor immunotherapy.
    Nishimura T; Nakamura Y; Takeuchi Y; Tokuda Y; Iwasawa M; Kawasaki A; Okumura K; Habu S
    J Immunol; 1992 Jan; 148(1):285-91. PubMed ID: 1345787
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evidence for IL-2 independent proliferation in human T cells.
    Laing TJ; Weiss A
    J Immunol; 1988 Feb; 140(4):1056-62. PubMed ID: 2830333
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Activation of the interleukin 2 pathway precedes CD3-T cell receptor expression in thymic development. Differential growth requirements of early and mature intrathymic subpopulations.
    Toribio ML; De la Hera A; Marcos MA; Márquez C; Martínez C
    Eur J Immunol; 1989 Jan; 19(1):9-15. PubMed ID: 2522051
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Receptor-specific inhibition of bone marrow erythropoiesis by recombinant DNA-derived interleukin-2.
    Burdach SE; Levitt LJ
    Blood; 1987 May; 69(5):1368-75. PubMed ID: 3105620
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Co-stimulation of T cell proliferation by transforming growth factor-beta 1.
    Lee HM; Rich S
    J Immunol; 1991 Aug; 147(4):1127-33. PubMed ID: 1831218
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differential effect of tumour necrosis factor on human thymocyte subpopulations.
    Muñoz-Fernández MA; Pimentel-Muiños FX; González A; Gambon F; Alvarez-Vallina L; Fresno M
    Immunology; 1992 Jul; 76(3):439-45. PubMed ID: 1526653
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Athymic nude CD4+8- T cells produce IL-2 but fail to proliferate in response to mitogenic stimuli.
    Kung JT; Thomas CA
    J Immunol; 1988 Dec; 141(11):3691-6. PubMed ID: 2972776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.